Deerfield Management as of March 31, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 105 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 6.6 | $170M | 2.2M | 76.03 | |
| Horizon Pharma | 6.2 | $162M | 11M | 14.78 | |
| NxStage Medical | 3.9 | $101M | 3.7M | 26.83 | |
| Mylan Nv | 3.8 | $97M | 2.5M | 38.99 | |
| Horizon Pharma Plc convertible security | 3.2 | $83M | 90M | 0.92 | |
| Gilead Sciences (GILD) | 3.1 | $82M | 1.2M | 67.92 | |
| Dbv Technologies S A | 2.4 | $61M | 1.7M | 35.22 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.3 | $60M | 63M | 0.96 | |
| Portola Pharmaceuticals | 2.2 | $57M | 1.5M | 39.19 | |
| Blueprint Medicines (BPMC) | 2.1 | $55M | 1.4M | 39.99 | |
| Anthem (ELV) | 2.0 | $53M | 318k | 165.38 | |
| Gw Pharmaceuticals Plc ads | 2.0 | $52M | 426k | 120.94 | |
| Endologix Inc note 2.250%12/1 | 1.9 | $49M | 51M | 0.96 | |
| Kempharm Inc note 5.500% 2/0 | 1.8 | $46M | 75M | 0.61 | |
| Centene Corporation (CNC) | 1.7 | $43M | 604k | 71.26 | |
| Lannett Company | 1.6 | $41M | 1.9M | 22.35 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.6 | $40M | 41M | 0.99 | |
| Intercept Pharmas conv | 1.5 | $40M | 43M | 0.93 | |
| Flamel Technologies Sa | 1.5 | $39M | 4.1M | 9.68 | |
| Trn 4% 04/01/45 | 1.5 | $39M | 48M | 0.81 | |
| Editas Medicine (EDIT) | 1.5 | $38M | 1.7M | 22.32 | |
| Nevro (NVRO) | 1.5 | $38M | 403k | 93.70 | |
| Molina Healthcare Inc conv | 1.4 | $37M | 35M | 1.06 | |
| Aerie Pharmaceuticals | 1.4 | $36M | 796k | 45.35 | |
| Aetna | 1.3 | $34M | 267k | 127.55 | |
| McKesson Corporation (MCK) | 1.3 | $34M | 229k | 148.26 | |
| Nevro Corp note 1.750% 6/0 | 1.3 | $34M | 28M | 1.22 | |
| Mallinckrodt Pub | 1.2 | $33M | 729k | 44.57 | |
| Vanda Pharmaceuticals (VNDA) | 1.2 | $32M | 2.3M | 14.00 | |
| eHealth (EHTH) | 1.2 | $32M | 2.6M | 12.04 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.2 | $32M | 22M | 1.43 | |
| Loxo Oncology | 1.2 | $32M | 753k | 42.08 | |
| Xencor (XNCR) | 1.2 | $31M | 1.3M | 23.92 | |
| Walgreen Boots Alliance | 1.1 | $30M | 356k | 83.05 | |
| Universal American | 1.1 | $28M | 2.8M | 9.97 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $26M | 3.1M | 8.40 | |
| Ascendis Pharma A S (ASND) | 1.0 | $26M | 929k | 28.00 | |
| Syros Pharmaceuticals | 1.0 | $26M | 1.6M | 15.93 | |
| Epizyme | 0.9 | $24M | 1.4M | 17.15 | |
| Wright Med Group Inc note 2.000% 2/1 | 0.9 | $24M | 20M | 1.20 | |
| Audentes Therapeutics | 0.9 | $24M | 1.4M | 17.04 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $24M | 846k | 27.75 | |
| Galapagos Nv- (GLPG) | 0.9 | $22M | 260k | 86.19 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.8 | $21M | 523k | 39.86 | |
| Axogen (AXGN) | 0.7 | $19M | 1.8M | 10.45 | |
| Fluidigm Corporation convertible cor | 0.7 | $19M | 28M | 0.67 | |
| Recro Pharma | 0.7 | $18M | 2.1M | 8.74 | |
| Healthways Inc note 1.500% 7/0 | 0.7 | $18M | 12M | 1.54 | |
| Aac Holdings | 0.7 | $17M | 2.0M | 8.53 | |
| Valeant Pharmaceuticals Int | 0.6 | $17M | 1.5M | 11.03 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $16M | 943k | 17.27 | |
| Selecta Biosciences | 0.6 | $15M | 1.1M | 14.32 | |
| Spark Therapeutics | 0.6 | $15M | 283k | 53.34 | |
| Neos Therapeutics | 0.6 | $15M | 2.1M | 7.20 | |
| Humana (HUM) | 0.6 | $14M | 69k | 206.14 | |
| Impax Laboratories Inc conv | 0.5 | $14M | 17M | 0.82 | |
| Invuity | 0.5 | $13M | 1.7M | 7.95 | |
| Wave Life Sciences (WVE) | 0.5 | $13M | 472k | 27.50 | |
| Akari Therapeutics | 0.5 | $13M | 1.2M | 11.07 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $11M | 375k | 29.82 | |
| Nivalis Therapeutics | 0.4 | $11M | 3.7M | 2.92 | |
| Ardelyx (ARDX) | 0.4 | $11M | 842k | 12.65 | |
| Jounce Therapeutics | 0.4 | $10M | 469k | 21.99 | |
| Array BioPharma | 0.4 | $10M | 1.1M | 8.94 | |
| Tesaro | 0.4 | $10M | 66k | 153.86 | |
| Steadymed | 0.4 | $10M | 1.8M | 5.80 | |
| Bluebird Bio | 0.4 | $9.7M | 107k | 90.90 | |
| Oxford Immunotec Global | 0.4 | $9.5M | 617k | 15.49 | |
| Allscripts Healthcare So conv | 0.4 | $9.7M | 9.7M | 1.00 | |
| Dex (DXCM) | 0.4 | $9.4M | 111k | 84.73 | |
| Glaukos (GKOS) | 0.4 | $9.2M | 180k | 51.30 | |
| Globus Med Inc cl a (GMED) | 0.3 | $9.1M | 308k | 29.62 | |
| Sage Therapeutics (SAGE) | 0.3 | $8.7M | 122k | 71.07 | |
| Axovant Sciences | 0.3 | $8.5M | 568k | 14.94 | |
| Alimera Sciences | 0.3 | $8.2M | 5.9M | 1.40 | |
| Myovant Sciences | 0.3 | $8.3M | 705k | 11.74 | |
| Tg Therapeutics (TGTX) | 0.3 | $8.2M | 700k | 11.65 | |
| Sierra Oncology | 0.3 | $7.6M | 5.0M | 1.53 | |
| Nanostring Technologies (NSTGQ) | 0.3 | $7.0M | 352k | 19.87 | |
| Essa Pharma | 0.3 | $6.6M | 2.1M | 3.12 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $6.4M | 2.0M | 3.23 | |
| Kite Pharma | 0.2 | $6.4M | 81k | 78.49 | |
| Myokardia | 0.2 | $5.6M | 425k | 13.15 | |
| Kempharm | 0.2 | $5.3M | 1.1M | 4.90 | |
| Five Prime Therapeutics | 0.2 | $5.0M | 138k | 36.15 | |
| Sangamo Biosciences (SGMO) | 0.2 | $4.4M | 838k | 5.20 | |
| Acorda Therap note 1.75% 6/15 | 0.2 | $4.3M | 5.0M | 0.85 | |
| Foamix Pharmaceuticals | 0.2 | $4.0M | 817k | 4.95 | |
| Ra Pharmaceuticals | 0.1 | $3.8M | 178k | 21.29 | |
| Aralez Pharmaceuticals | 0.1 | $3.5M | 1.6M | 2.14 | |
| BioScrip | 0.1 | $3.4M | 2.0M | 1.70 | |
| Agile Therapeutics | 0.1 | $3.1M | 972k | 3.20 | |
| Genocea Biosciences | 0.1 | $2.9M | 479k | 6.09 | |
| Adeptus Health Inc-class A | 0.1 | $2.9M | 1.6M | 1.80 | |
| Scynexis | 0.1 | $2.9M | 1.0M | 2.76 | |
| CAS Medical Systems | 0.1 | $2.6M | 1.8M | 1.45 | |
| pSivida | 0.1 | $2.6M | 1.5M | 1.72 | |
| Proteon Therapeutics | 0.1 | $2.3M | 1.3M | 1.75 | |
| Tivity Health | 0.1 | $2.2M | 76k | 29.11 | |
| Voyager Therapeutics (VYGR) | 0.1 | $1.6M | 118k | 13.24 | |
| Threshold Pharmaceuticals | 0.1 | $1.3M | 2.2M | 0.57 | |
| Streamline Health Solutions | 0.0 | $676k | 663k | 1.02 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $767k | 37k | 20.77 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $523k | 38k | 13.72 | |
| Obalon Therapeutics | 0.0 | $224k | 21k | 10.69 |
